On the other hand, a wealth of preclinical studies reported that blocking IL-1 signaling through the administration of IL-1Ra provided neuroprotective effects, with decreased tissue loss and attenuated cognitive deficits, in ischemic stroke [165,166,167]. The gene discussed is IL1B; the disease is Cognitive impairment.